日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

AstraZeneca to build $200m center in China

Updated: 2011-10-12 09:56

By Ma Zhenhuan (China Daily)

  Comments() Print Mail Large Medium  Small 分享按鈕 0

AstraZeneca to build $200m center in China

AstraZeneca PLC workers load blister strips onto a packing line at a factory in Macclesfield, United Kingdom. The UK-based medical company will create 600 jobs by building a new factory in Taizhou, Jiangsu province. [Photo / Bloomberg]

SHANGHAI - AstraZeneca PLC, one of the world's leading pharmaceutical companies, said it would invest $200 million to launch a new manufacturing facility in China to meet growing demand, including in rural areas.

Construction work on the project, in the China Medical City in Taizhou of East China's Jiangsu province, is scheduled for completion by the end of 2013, creating approximately 600 jobs.

This will be London-based AstraZeneca's largest single investment in a manufacturing facility globally. The new plant will produce intravenous and oral solid products, the company said.

"The new facility will significantly enhance our capacity and allow us to meet the growing healthcare demand of the Chinese population, and help us expand into the 900 million (rural) people outside of the big cities and hospitals," Mark Mallon, president of AstraZeneca China, told China Daily in an exclusive interview on Monday.

"It will also allow us to free up some capacity at our existing manufacturing facility in Wuxi, Jiangsu, to bring on more new innovative products that will be launched over the next few years," he added.

The Chinese pharmaceutical market grew from $10 billion in 2004 to $41 billion in 2010, according to market research agency IMS Health Inc, and it is expected to reach $102 billion by 2015.

Mallon said that he believes the Chinese government's focus on healthcare reform and investment in improving healthcare infrastructure and expanding insurance coverage will continue to drive the company's business growth and increase access to quality medicines over the longer term.

AstraZeneca will launch two new products, Faslodex, a treatment for breast cancer, and Onglyza, a new treatment for Type-2 Diabetes, in China this year.

Mallon also mentioned that the company is planning to launch Brilinta, an oral antiplatelet treatment for acute coronary syndrome, next year in China.

With an enhanced manufacturing capacity and the launch of more innovative new medicines, the company is planning to produce more affordable medicines for Chinese patients. It will adopt a multi-channel approach to sell its products to markets beyond big cities and hospitals.

Aside from the medical sales representatives who deal with individual physicians in big cities, the company has developed a team of about 100 customer service representatives who organize educational programs for small clinics and community health centers in China's rural areas.

It will also set up an inbound and outbound call center to reach out to healthcare professionals through phone calls, helping them learn more about AstraZeneca products, he said.

The company, which entered China in 1993, has invested about $500 million in the country, including an innovation center in Zhangjiang, Shanghai.

主站蜘蛛池模板: 在线精品亚洲欧美日韩国产 | 草草草在线 | 91插插插影库永久免费 | 国产又粗又大又长 | 国产成人免费看一级大黄 | 久久99久久久久久久久久久 | 国产91精品一区二区 | 日本高清视频网站 | 永久免费精品视频 | 毛片天天看 | 国产哺乳奶水91在线播放 | 欧美国产精品一区 | 欧美一区二区三区精品 | 开心激情五月网 | 91看片在线播放 | 四虎免费av| av青青草原 | 国产女人在线观看 | 99精品视频网站 | 麻豆成人免费 | 国产欧美精品区一区二区三区 | 久久综合91 | 欧美不卡一区二区 | 色噜噜日韩精品欧美一区二区 | 日本一级片在线观看 | 色动态 | 日韩理论在线 | 亚洲天堂一区在线观看 | 免费看三级黄色片 | 国产xxxxxx| 日日射天天操 | 欧美另类videoxo高潮 | 特级丰满少妇 | 欧美一二三区在线观看 | 国产精品久久久久久69 | 一区二区三区免费视频观看 | 四虎影院网站 | 毛片毛片毛片毛片 | 日本黄色小视频 | 天天看天天摸天天操 | 亚洲免费在线视频观看 |